ARCHIVES

Addition of Cobimetinib Boosts PFS in BRAF Mutation-Positive Patients in Phase III Trial

This article is from The Cancer Letter archive.

Vol. 37 No. 7 | July 25, 2014

Download PDF Visit The Full Archive

Related Articles

Three Venerable Acronyms Fade Away As Cooperative Groups Form “Alliance”

June 17, 2011

Harold Varmus To Receive National Medal Of Science; Gates Foundation Hires Klausner.

May 17, 2002

NCI Intends To Extend OSCC Two More Years

October 3, 1986

NCI Programs: Researchers Take “Director’s Challenge” to Develop Molecular Profiles of Tumors

December 10, 1999

Ford Asks NCAB for Scientific Basis For Regulation Of Tar and Nicotine Content Of Cigarettes By Dec.

October 25, 1974

NCI Clarifies Plan For Review Of Epidemiologic Research

June 1, 2001